Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.3 BRL | +0.84% | +1.70% | +5.83% |
02:28pm | Utah Continued to Face Issues After UnitedHealth Claimed Progress With Hack Repairs | MT |
05-20 | UnitedHealth's unit to launch new drug pricing model next year | RE |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Analyst opinion has improved significantly over the past four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- With a 2024 P/E ratio at 28.88 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Sector: Managed Healthcare
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+5.83% | 482B | - | ||
+15.70% | 127B | A- | ||
+12.33% | 95.56B | B- | ||
-22.32% | 42.85B | A- | ||
+5.65% | 41.84B | B- | ||
-5.26% | 20.06B | B- | ||
-26.14% | 2.61B | C+ | ||
-13.47% | 1.42B | B- | ||
-2.62% | 460M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- UNH Stock
- UNHH34 Stock
- Ratings UnitedHealth Group Incorporated